Ibrahim C Haznedaroglu Selected Research

Hemostatics (Antihemorrhagics)

10/2020	Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
1/2019	Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach.
1/2016	Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level.
9/2014	Effective management of hemoptysis via endobronchial application of Ankaferd hemostat.
5/2014	Next generation nanomedicine in the genesis of "Ankaferd blood stopper nanohemostat": a novel chimeric topical hemostatic agent for clinical hemorrhages.
1/2013	Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.
11/2012	Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses.
7/2012	Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
10/2011	Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits.
9/2011	Ankaferd hemostat in the management of gastrointestinal hemorrhages.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ibrahim C Haznedaroglu Research Topics

Disease

25	Hemorrhage 01/2019 - 07/2002
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2021 - 05/2005
5	Thrombocytopenia (Thrombopenia) 01/2010 - 07/2002
4	Thrombocytosis (Thrombocythemia) 01/2010 - 12/2003
4	Thrombosis (Thrombus) 07/2008 - 04/2006
3	Inflammation (Inflammations) 10/2020 - 09/2006
3	Wounds and Injuries (Trauma) 10/2020 - 01/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2020 - 05/2006
3	Primary Myelofibrosis (Myelosclerosis) 08/2015 - 01/2006
3	Leukemia 12/2013 - 04/2002
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2012 - 01/2008
3	Obesity 07/2006 - 09/2005
2	Neoplasms (Cancer) 01/2019 - 12/2013
2	Rhabdomyolysis 04/2016 - 06/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2013 - 04/2006
2	Necrosis 09/2011 - 10/2010
2	Liver Diseases (Liver Disease) 07/2011 - 07/2003
2	Hodgkin Disease (Hodgkin's Disease) 12/2010 - 11/2007
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2010 - 07/2008
2	Insulin Resistance 05/2010 - 01/2006
2	Legg-Calve-Perthes Disease (Perthes Disease) 12/2008 - 07/2005
2	Pancytopenia 01/2008 - 07/2002
2	Systemic Scleroderma (Systemic Sclerosis) 01/2006 - 08/2003
2	Unstable Angina 09/2005 - 05/2005
2	Rheumatoid Arthritis 05/2005 - 10/2004
1	Mucositis 10/2020
1	COVID-19 10/2020
1	Multiple Myeloma 05/2020
1	Frailty 05/2020
1	Acute Promyelocytic Leukemia 02/2020
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Philadelphia Chromosome 02/2018
1	Fibrosis (Cirrhosis) 08/2015
1	Pancreatic Fistula (Pancreatic Fistulas) 06/2015
1	Hemoptysis 09/2014
1	Epistaxis (Nosebleed) 10/2011
1	Peptic Ulcer (Peptic Ulcers) 09/2011
1	Hepatocellular Carcinoma (Hepatoma) 09/2011
1	Sclerosis 07/2011
1	Esophageal and Gastric Varices (Esophageal Varices) 03/2011
1	Varicose Veins (Varicose Vein) 03/2011

Drug/Important Bio-Agent (IBA)

22	Hemostatics (Antihemorrhagics)IBA 10/2020 - 11/2003
21	ankaferd blood stopperIBA 10/2020 - 01/2009
7	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 05/2005
6	ReninIBA 12/2013 - 04/2002
5	Tyrosine Kinase InhibitorsIBA 10/2021 - 10/2013
5	Pharmaceutical PreparationsIBA 10/2020 - 10/2004
4	SolutionsIBA 09/2014 - 01/2009
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2011 - 04/2002
3	Dasatinib (BMS 354825)FDA Link 04/2016 - 06/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2010 - 07/2002
3	ThrombomodulinIBA 12/2008 - 08/2003
3	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 06/2008 - 04/2006
2	Immunologic Factors (Immunomodulators)IBA 10/2020 - 08/2010
2	Hormones (Hormone)IBA 10/2020 - 01/2006
2	AngiotensinsIBA 10/2020 - 05/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2020 - 08/2003
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
2	nilotinib FDA Link 02/2018 - 08/2015
2	Biological ProductsIBA 07/2011 - 12/2008
2	Triglycerides (Triacylglycerol)IBA 05/2010 - 09/2005
2	AndrogensIBA 05/2010 - 07/2008
2	SelectinsIBA 05/2010 - 10/2004
2	LipidsIBA 05/2010 - 05/2007
2	HDL CholesterolIBA 05/2010 - 09/2005
2	CholesterolIBA 05/2010 - 09/2005
2	Glycoproteins (Glycoprotein)IBA 01/2008 - 09/2005
2	Thrombopoietin (c-mpl Ligand)IBA 01/2006 - 02/2005
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 07/2005 - 05/2005
2	E-SelectinIBA 10/2004 - 08/2003
1	fibrinogen gamma'IBA 10/2020
1	Proteinase-Activated ReceptorsIBA 10/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	Bortezomib (Velcade)FDA Link 05/2020
1	CreatinineIBA 01/2019
1	ribosomal protein L5IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Protein Deglycase DJ-1IBA 01/2019
1	HydrolasesIBA 01/2019
1	karyopherin alpha 2IBA 01/2019
1	ruxolitinibIBA 01/2012
1	GelatinIBA 10/2011
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2011
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2011
1	Ethanol (Ethyl Alcohol)IBA 09/2011
1	CyanoacrylatesIBA 03/2011
1	GlobulinsIBA 01/2011
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2011
1	Thomsen-Friedenreich antibodiesIBA 01/2011

Therapy/Procedure

5	Therapeutics 03/2011 - 08/2003
4	Drug Therapy (Chemotherapy) 01/2013 - 04/2002
2	Induction Chemotherapy 02/2020 - 01/2019
2	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2013
2	Nephrectomy 01/2013 - 08/2010
1	Splenectomy 01/2019
1	Pancreatectomy 06/2015
1	Catheters 03/2011
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 03/2011